Geode Capital Management, LLC Oragenics Inc Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.11 - $15.59 $221 - $31,367	-2,012 Reduced 0.27%	747,027 $78,000
Q2 2022 Aug 12, 2022	BUY	$0.24 - $0.42 $4,256 - $7,448	17,735 Added 2.43%	749,039 $259,000
Q2 2021 Aug 13, 2021	BUY	$0.6 - $0.89 $117,471 - $174,248	195,785 Added 36.56%	731,304 $515,000
Q1 2021 May 12, 2021	BUY	$0.52 - $1.52 $158,054 - $462,004	303,950 Added 131.26%	535,519 $485,000
Q3 2020 Nov 13, 2020	BUY	$0.56 - $1.49 $21,468 - $57,120	38,336 Added 19.84%	231,569 $133,000
Q2 2020 Aug 13, 2020	BUY	$0.39 - $0.83 $75,360 - $160,383	193,233 New	193,233 $134,000
Q1 2018 May 15, 2018	SELL	$1.6 - $3.17 $143,905 - $285,112	-89,941 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$2.1 - $4.6 $188,876 - $413,728	89,941	89,941 $21,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $33.8M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.